Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials.

Diabetes Obes Metab · 2022 · PMC9314948 · PMID 35170192

Europe PMC DOI

hedged sentence

0.0805

closest p · 1.6× alpha

0.0805

boldest claim

The sentences

did not reach statistical significancep = .0805so close (0.05 < p ≤ 0.1)

In the once‐daily bremelanotide group, weight loss was numerically greater than weight loss observed in placebo‐treated subjects, but the difference did not reach statistical significance ( p = .0805).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.